Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2016.6.21

Burdashkina K.G., Bychko G.N., Kirkovsky V.V., Rineyskaya O.N.
Restricted proteolysis products: approaches to the detection and diagnostic means for the evaluation of the pathology severity in endogenous intoxication
Belarusian State Medical University, Minsk, Republic of Belarus

Vestnik VGMU. 2016;15(6):21-27.

Abstract.
The review article is devoted to the urgent problem of the evaluation of the pathological process course severity in conditions accompanied by endogenous intoxication.
Various methodological approaches to the middle molecular peptide fraction determination as the main marker of endotoxemia are considered in this article. Modern data on quantitative and qualitative analysis of protein-peptide components in blood plasma by hydrophilic/hydrophobic properties, the peculiarities of proteinase-inhibitor system functioning in different types of pathology are presented. The analysis of molecular weight distribution nature of the products of intermediate protein metabolism will enable the increase of the reliability of the pathological process diagnosis and detoxication measures effectiveness monitoring.
Key words: restricted proteolysis products, proteinase-inhibitor system, endogenous intoxication.

References

1. Vitkina TI. Average molecules in assessment of level of endogenic intoxication at chronic not obstructive bronchitis. Zdorov'e Med Ekologiia Nauka. 2014;(2):70-2. (In Russ.)
2. Galaktionov SG, Tseytin VM, Leonova VI, Nikolaychik VV, Mikhneva LM. The peptides of the group of «middle molecules». Bioorgan Khimiia. 1984;(10(1):5-17. (In Russ.)
3. Vanholder R, Van Laecke S, Glorieux G. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol. 2008 Mar-Apr;21(2):146-60.
4. Fürst P, Zimmerman L, Bergström J. Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol. 1976 Apr;3(2):178-88.
5. Babb AL, Ahmad S, Bergström J, Scribner BH. The middle molecule hypothesis in perspective. Am J Kidney Dis. 1981 Jul;1(1):46-50.
6. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43.
7. Kosinets AN, Kirpichenok LN. Proteinases and their inhibitors in purulent surgery and an oncology. Vitebsk, RB; 2003. 409 р. (In Russ.)
8. Sikorskaya TA, Bychko GN, Lukyanov AM. Imbalance, proteinase-inhibitory system and the level of endotoxemia in patients with microbe-associated psoriasis. Med Zhurn. 2015;(1):116-21. (In Russ.)
9. Voytovich TN, Bychko GN, Chistyy AG. Features of proteinazo-inhibitory system at patients with a mucoviscidosis. Med Zhurn. 2013;(2):59-62. (In Russ.)
10. Malakhova MYa. Endogenic intoxication as reflection of compensatory reorganization of metabolic processes in an organism. Efferent Terapiia. 2000;(4):3-14. (In Russ.)
11. Karyakina EV, Belova SV. Molecules of average weight as integrated indicator of disturbances (review of literature). Klin Lab Diagnostika. 2004;(3):3-8. (In Russ.)
12. Bunyatyan ND, Vlasov AP, Nachkina EI, Kochkarova RR, Shibitov VA, Kargaeva TN, et al. Functional and systemic reactions of an organism at endointoxication and their correction. Farmatsiia. 2011;(6):43-6. (In Russ.)
13. Nazarenko GI, Kishkun AA. Laboratory diagnostic methods of medical emergencies. Moscow, RF: Meditsina; 2002. 568 р. (In Russ.)
14. Ermakov AV. Diagnostic possibilities of using the method of determining the level of medium molecular compounds in the practice of medicine. Problemy Ekspertizy v Meditsine. 2005;5(17-1):27-9. (In Russ.)
15. Cherniy VI, Novikova RI, Kostenko VS, Shramenko EK, Logvinenko LV. Use of efferent methods of therapy at critical conditions: metod rek. Donetsk, Ukraine; 2007. 15 р. (In Russ.)
16. Shepilova ZhI, Balyakin SO. Diagnostic value of determination of middle molecules in some of the destructive pathological processes. Lab Delo. 1984;(9):546-8. (In Russ.)
17. Gabrielyan NI. Screening method for determination of middle molecules in biological fluids: metod rek. Moscow, RF; 1985. 17 с. (In Russ.)
18. Nikolaychik VV, Kirkovskiy VV, Moin VM, Mazur LI, Lobacheva GA, Bychko GN, et al. «Average molecules» – educations and ways of definition. Lab Delo. 1989;(28):31-3. (In Russ.)
19. Malakhova MYa. Method of registration of endogenic intoxication: metod rek. Saint-Petersburg, RF; 1995. 33 р. (In Russ.)
20. Vasilenko DV, Alabovskiy VV, Maslov AI, Ostroushko AP. Medium molecular peptides in the blood plasma in diabetic nephropathy. Zhurn Teoret Prakt Meditsiny. 2004;2(3):203-05. (In Russ.)
21. Nagoev BS. Value of definition of average molecules in a blood plasma at infectious diseases of a virus and bacterial etiology. Klin Lab Diagnostika. 2000;(1):9-11. (In Russ.)
22. Afanasyeva AN. Comparative assessment of level of endogenic intoxication at persons of different age groups. Klin Lab Diagnostika. 2004;(6):11-3. (In Russ.)
23. Nikolaychik VV, Moin VM, Kirkovskiy VV, Mazur LI, Lobacheva GA, et al. Way of definition of «average molecules». Lab Delo. 1991;(10):13-8. (In Russ.)
24. Shvab OV, Trishkin SV, Shenel EN, Vaskovekiy BV, Sukhikh GT, Demushkin VP. The analysis of peptides from tissues of animals and plants. Bioorgan Khimiia. 1999;25(1):20-4. (In Russ.)
25. Yang P, McCabe T, Pursch M. Practical comparison of LC columns packed with different superficially porous particles for the separation of small molecules and medium size natural products. J Sep Sci. 2011 Nov;34(21):2975-82. doi: http://dx.doi.org/10.1002/jssc.201100530
26. Osterman L. Chromatography of proteins and nucleic acids. Moscow, RF: Nauka, 1985. 536 р. (In Russ.)
27. Lokhov PG, Maslov DL, Trifonova OP, Balashova EE, Archakov AI. Mass spectrometry of blood low-molecular fraction as a method for unification of therapeutic drug monitoring. Biomed Khim. 2014 Mar-Apr;60(2):201-16.
28. Lokhov PG, Kharybin ON, Archakov AI. Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites. Int J Mass Spect. 2012;309:200-5.
29. Trifonova OP, Lokhov PG, Archakov AI. Metabolomny profiling of a blood. Biomed Khimiia. 2014;60(3):281-94. (In Russ.)
30. Toshimitsu N. Update of uremic toxin research by mass spectrometry. Mass Spec Rev. 2011;30(3):510-21. doi: http://dx.doi.org/10.1002/mas.20323
31. Kirkovskiy VV. Physical and chemical methods of correction of a homeostasis. Moscow, RF: Russkii vrach; 2012. 216 р. (In Russ.)
32. Lobko NF, Konev SV. A new method for determining the severity status of patients with pulmonary tuberculosis according to the level of tyrosine-containing peptides. Izv Nats Akademii Nauk Belarusi Ser Med Nauk. 2005;(2):20-2. (In Russ.)
33. Smolina NV, Syreyshchikova TI, Uzbekov MG, Dobretsov GE. V: Fluorescent probes as a source of clinically relevant information. Fundamental'nye nauki – meditsine: biofizicheskie meditsinskie tekhnologii. 2015;2;293-327. (In Russ.)
34. Dozio E, Di Gaetano N, Findeisen P, Corsi Romanelli MM. Glycated albumin: from biochemistry and laboratory medicine to clinical practice. Endocrine. 2016 Sep. doi: http://dx.doi.org/10.1007/s12020-016-1091-6
35. Ivanova SV, Kirpichenok LN, Kunder EV. Correlation analysis of fluorescence and proteolytic indices in the serum and synovial fluid in arthritis. Vestn VGMU. 2010;9(3):162-9. (In Russ.)
36. Korolenko EA, Korolik EV, Dikevich AE, Korolik AK, Kirkovskiy VV. Spectral methods of investigation of structural-functional state of the main transport protein of blood plasma of patients with dyslipidemia. Novosti Mediko-Biol Nauk. 2013;7(1):18-22. (In Russ.)
37. Karyagina IYu, Zarembskiy RA, Balyabina MD. Using the method of complex determination of the activity of trypsin-like proteases, el-antitrypsin and -2-macroglobulin in gastroenterological practice. Lab Delo. 1990;(2):10-3. (In Russ.)
38. Ermola YuA, Fomochkina II, Kubyshkin AV. Local and systemic changes of indicators of nonspecific proteinases and their inhibitors at experimental peritonitis. Ukraїn Med Al'manakh. 2012;15(5):80-2. (In Russ.)
39. Fomochkina II, Kubyshkin AV. Pathogenetic value of proteinases – inhibitory system in development of local and systemic pathology. Patologiia. 2012;(2):50-4. (In Russ.)
40. Ivanova SV, Kirpichenok LN, Kunder EV. Spectral-fluorescence and proteolytic activity of blood serum and synovial fluid in arthritis. Zhurn GrGMU. 2009;(4):73-7. (In Russ.)

Information about authors:
Burdashkina K.G. – postgraduate of the Chair of Bioorganic Chemistry, Belarusian State Medical University;
Bychko G.N. – Candidate of Biological Sciences, leading research officer of the Scientific-Research Department, Belarusian State Medical University;
Kirkovsky V.V. – Doctor of Medical Sciences, professor, principal research officer of the Scientific- Research Department, Belarusian State Medical University;
Rineyskaya O.N. – Candidate of Medical Sciences, associate professor, head of the Chair of Bioorganic Chemistry, Belarusian State Medical University.

Correspondence address: Republic of Belarus, 210116, Minsk, 83 Dzerzhinsky ave., Belarusian State Medical University, Chair of Bioorganic Chemistry. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра.  – Burdashkina Kristina G.

http://dx.doi.org/10.1002/mas.20323

Поиск по сайту